CHM chimeric therapeutics limited

Ann: CLTX CAR T data shows regional control of tumour recurrence, page-11

  1. 717 Posts.
    lightbulb Created with Sketch. 585
    With regards to the ability of CLTX-CAR T cells to target the glioma stem cell (GSC) sub-population, which is critical to preventing recurrence:

    https://hotcopper.com.au/data/attachments/3822/3822084-21724a0e80a3567728361a81b8a2ba30.jpg

    This was extracted from the foundational publication in the prestigious Science Translational Medicine journal, which is an excellent resource for anyone interested in delving further into the CLTX-CAR T technology.

    https://www.chimerictherapeutics.com/wp-content/uploads/2020/11/Wang-CLTXCARs-STM-2020.pdf

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $8.060M
Open High Low Value Volume
0.4¢ 0.4¢ 0.4¢ $20.21K 5.053M

Buyers (Bids)

No. Vol. Price($)
2 2213046 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 13563373 20
View Market Depth
Last trade - 15.01pm 24/06/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.